newsfilter
← Latest News
PR Newswire·

RegeneRx Biopharmaceuticals, Inc. Closes $2 Million Private Placement

ROCKVILLE, Md., July 1, 2021 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCQB:RGRX) ("RegeneRx"), a clinical-stage drug development company focused on tissue protection, repair and regeneration), today announced that it closed its previously an